Furthermore, they pointed to the possible risk of more frequent development of leukemia in patients with partial defect of gene determining the synthesis of perforin.49 In patients with MDS and AML percentage of NK, expressing perforin was also lower than in the control group.43 This evidence concerns the gene PRF1 and leukemia.